Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sozzi

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Cancer Research|January 1, 1991
Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patientsG Sozzi, M Miozzo, E Tagliabue, et al.
British Journal of Cancer|March 1, 1990
Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL)G Sozzi, M Miozzo, A Orazi, et al.
The Journal of Pathology|August 26, 1998
Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22S Pilotti, G Della Torre, C Lavarino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Immunocytochemical markers in stage I lung cancer: relevance to prognosisU Pastorino, S Andreola, E Tagliabue, et al.
Genes, Chromosomes & Cancer|September 1, 1994
The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2F Minoletti, M G Butti, S Coronelli, et al.
Genes, Chromosomes & Cancer|May 1, 1995
Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberansF Minoletti, M Miozzo, F Pedeutour, et al.
Tumori|December 23, 1998
Limited role of TP53 and TP53-related genes in myxoid liposarcomaS Pilotti, C Lavarino, A Mezzelani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2019
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacyU Pastorino, M Silva, S Sestini, et al.
Cell Death & Disease|December 16, 2014
Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interactionO Fortunato, M Boeri, M Moro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Somatic genetic changes in lung cancer and precancerous lesionsV Sundaresan, A Heppell-Parton, N Coleman, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Cancer Research|January 1, 1991
Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patientsG Sozzi, M Miozzo, E Tagliabue, et al.
British Journal of Cancer|March 1, 1990
Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL)G Sozzi, M Miozzo, A Orazi, et al.
The Journal of Pathology|August 26, 1998
Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22S Pilotti, G Della Torre, C Lavarino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Immunocytochemical markers in stage I lung cancer: relevance to prognosisU Pastorino, S Andreola, E Tagliabue, et al.
Genes, Chromosomes & Cancer|September 1, 1994
The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2F Minoletti, M G Butti, S Coronelli, et al.
Genes, Chromosomes & Cancer|May 1, 1995
Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberansF Minoletti, M Miozzo, F Pedeutour, et al.
Tumori|December 23, 1998
Limited role of TP53 and TP53-related genes in myxoid liposarcomaS Pilotti, C Lavarino, A Mezzelani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2019
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacyU Pastorino, M Silva, S Sestini, et al.
Cell Death & Disease|December 16, 2014
Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interactionO Fortunato, M Boeri, M Moro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Somatic genetic changes in lung cancer and precancerous lesionsV Sundaresan, A Heppell-Parton, N Coleman, et al.
Pageof 15